About the AlzMatch Study
The AlzMatch Study tests whether a single blood test, collected at community-based laboratories, can help speed clinical trial enrollment by identifying people more likely to experience changes in their brains associated with Alzheimer’s disease.
AlzMatch is helping us find people who are most eligible for Alzheimer’s prevention trials by way of a simple blood draw. AlzMatch is currently on hiatus and by invite-only. If you would like to be considered for the AlzMatch Study in the future, please begin participation in the APT Webstudy. Future invitations to AlzMatch will go out to eligible APT Webstudy participants.
Why should I join AlzMatch?
Am I eligible to join AlzMatch?
You may be eligible if you are:
- A current participant in the Alzheimer Prevention Trials (APT) Webstudy
- Over 50 years of age
- Have no diagnosis of dementia
What happens when I join AlzMatch?
Read & Sign Consent Form
Schedule Blood Draw Online
Visit a Local Quest for Blood Draw
Learn if Eligible to Screen for Research Study
How is the study funded?
The AlzMatch Study is funded by several organizations including:
- National Institutes of Health
- Gates Ventures
- Epstein Family Alzheimer’s Disease Research Collaboration
Who is involved with AlzMatch?
AlzMatch is being conducted in special partnership with the APT Webstudy, including leading Alzheimer’s disease researchers from the following institutions:
